Treatment with Insulin or Metformin for Type 2 Diabetes
Treatment with insulin or metformin in patients with type 2 diabetes does not reduce cardiovascular risk.
This emerges from a study by the Harvard Medical School and Brigham and Women’s Hospital, Boston.
The cardiovascular risk in patients with type 2 diabetes is not reduced by drugs such as insulin or metformin. That is, at least, which suggests a study by the Harvard Medical School and Brigham and Women’s Hospital in Boston (USA) published in the Journal of the American Medical Association (JAMA).
The paper concludes that treatment with insulin or the drug metformin reduced in patients with type 2 diabetes of recent onset inflammatory biological indicators, cardiovascular risk factors, such as C-reactive protein high sensitivity. However, it improved glucose control. Read more
Blog Directory
